Assessment of vessels in the eye with glaucoma eye drop (Ripasudil Hydrochloride Hydrate ophthalmic solution)

Assessment of aqueous column dilation with Ripasudil Hydrochloride Hydrate ophthalmic solution(GLANATEC ophthalmic solution 0.4%) - Assessment of aqueous column

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046665

Enrollment

Registered

2022-01-18

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

GLANATEC ophthalmic solution KISARATAN ophthalmic solution

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Healthy students

Exclusion criteria

Exclusion criteria: Glaucoma allergic conjunctivitis Pregnant or nursing mothers

Design outcomes

Primary

Measure	Time frame
width and flow rate of aqueous column Intraocular pressure at before and after usuing ophthalmic solution	—

Secondary

Measure	Time frame
IOP reduction rate	—

Countries

Japan

Contacts

Public ContactMarie Suzuki

Fukui Medical University Hospital Ophthalmology

marie.ohgoshi.0408@gmail.com0776613111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026